Optiscan Imaging Ltd

Optiscan Imaging Ltd company information, Employees & Contact Information

Optiscan Imaging Ltd (ASX: OIL) is a global leader in the development, manufacture and commercialisation of endomicroscopic digital imaging technology solutions for medical, translational and pre-clinical applications. Our unique technology offers real-time, 3D, in vivo imaging at the single-cell level, in a non-destructive manner that enables clinicians to make immediate informed decisions. We are driven by delivering digital healthcare solutions giving healthcare providers and researchers high quality, live, microscopic images and associated tools. Our technology helps facilitate earlier detection and management of disease thus improving patient outcomes and reducing the cost of curative medicine and associated procedures within healthcare systems. We are united in the common pursuit of revolutionising healthcare with live digital microscopic solutions that enable immediate informed decisions, provide economic efficiencies within health systems and improve patient outcomes.

Company Details

Employees
30
Founded
-
Address
16 Miles St, Mulgrave,victoria 3170,australia
Phone
61395383333
Email
in****@****can.com
Industry
Medical Equipment Manufacturing
NAICS
Medical Equipment and Supplies Manufacturing
Surgical and Medical Instrument Manufacturing
Surgical Appliance and Supplies Manufacturing
Dental Equipment and Supplies Manufacturing
Ophthalmic Goods Manufacturing
Dental Laboratories
HQ
Mulgrave, Victoria
Looking for a particular Optiscan Imaging Ltd employee's phone or email?

Optiscan Imaging Ltd Questions

News

Optiscan Imaging (ASX:OIL) Seeks a Clearer Vision Amid Market Shifts - Kalkine Media

Optiscan Imaging (ASX:OIL) Seeks a Clearer Vision Amid Market Shifts Kalkine Media

Micropol debuts OptiScan for fast fiber testing - Defence Blog

Micropol debuts OptiScan for fast fiber testing Defence Blog

Optiscan advances three medical devices toward FDA submissions - ASX SMIDcaps - Proactive financial news

Optiscan advances three medical devices toward FDA submissions - ASX SMIDcaps Proactive financial news

Optiscan teams up with US drugmaker to support FDA submissions - The Sydney Morning Herald

Optiscan teams up with US drugmaker to support FDA submissions The Sydney Morning Herald

Biocurious: Behind Optiscan’s quest to ditch biopsies and bring pathology into the modern era - Stockhead

Biocurious: Behind Optiscan’s quest to ditch biopsies and bring pathology into the modern era Stockhead

Optiscan – Manufacturing an alternative to invasive diagnosis - Manufacturers' Monthly

Optiscan – Manufacturing an alternative to invasive diagnosis Manufacturers' Monthly

Optiscan unveils ‘digital pathology workhorse’ - The Australian

Optiscan unveils ‘digital pathology workhorse’ The Australian

Here's Why We're Not Too Worried About Optiscan Imaging's (ASX:OIL) Cash Burn Situation - Yahoo Finance

Here's Why We're Not Too Worried About Optiscan Imaging's (ASX:OIL) Cash Burn Situation Yahoo Finance

Optiscan Enhances Confocal Imaging for Next-Gen Diagnostics - Kalkine Media

Optiscan Enhances Confocal Imaging for Next-Gen Diagnostics Kalkine Media

Optiscan software breakthrough will bring pathologists to the bedside - The Sydney Morning Herald

Optiscan software breakthrough will bring pathologists to the bedside The Sydney Morning Herald

Optiscan Director Increases Stake Through Entitlement Issue - TipRanks

Optiscan Director Increases Stake Through Entitlement Issue TipRanks

Australian Med-Tech Firm to Open Minnesota Office - Twin Cities Business

Australian Med-Tech Firm to Open Minnesota Office Twin Cities Business

Health Check: Optiscan perfects 'dial a pathologist' platform; 4D Medical probes further FDA approval - Stockhead

Health Check: Optiscan perfects 'dial a pathologist' platform; 4D Medical probes further FDA approval Stockhead

Optiscan signs agreement with Monash to progress GI Scope - BiotechDispatch

Optiscan signs agreement with Monash to progress GI Scope BiotechDispatch

PRODUCT RELEASE: Micropol Launches OptiScan at DSEI 2025 - Nordic Defence Sector

PRODUCT RELEASE: Micropol Launches OptiScan at DSEI 2025 Nordic Defence Sector

Optiscan unveils high-tech imaging device for veterinarians - The Sydney Morning Herald

Optiscan unveils high-tech imaging device for veterinarians The Sydney Morning Herald

Optiscan Imaging Launches $17.75 Million Rights Issue for Medical Device Development - TipRanks

Optiscan Imaging Launches $17.75 Million Rights Issue for Medical Device Development TipRanks

Optiscan Imaging announces the appointment of US clinical and regulatory heads - BiotechDispatch

Optiscan Imaging announces the appointment of US clinical and regulatory heads BiotechDispatch

Melbourne breast cancer trial to test Optiscan imaging device - The Sydney Morning Herald

Melbourne breast cancer trial to test Optiscan imaging device The Sydney Morning Herald

ASX300 Innovation: Optiscan and Mayo Clinic Partner to Advance Robotic Breast Cancer Surgery - Kalkine Media

ASX300 Innovation: Optiscan and Mayo Clinic Partner to Advance Robotic Breast Cancer Surgery Kalkine Media

New Optiscan tech opens door to precision surgery market - The Sydney Morning Herald

New Optiscan tech opens door to precision surgery market The Sydney Morning Herald

Optiscan Imaging announces collaboration with Canadian-based company - BiotechDispatch

Optiscan Imaging announces collaboration with Canadian-based company BiotechDispatch

Optiscan’s Dr Camile Farah chats breaking into the US - The Australian

Optiscan’s Dr Camile Farah chats breaking into the US The Australian

Optiscan Imaging’s (ASX:OIL) Market Movement and Sector Insights - Kalkine Media

Optiscan Imaging’s (ASX:OIL) Market Movement and Sector Insights Kalkine Media

Optiscan Imaging and Mayo Clinic to collaborate on robotic breast cancer surgery technology - smallcaps.com.au

Optiscan Imaging and Mayo Clinic to collaborate on robotic breast cancer surgery technology smallcaps.com.au

Interim analysis shows accuracy of Optiscan Imaging platform - BiotechDispatch

Interim analysis shows accuracy of Optiscan Imaging platform BiotechDispatch

OptiScan raises $20m for bedside glucose monitoring system - Drug Delivery Business

OptiScan raises $20m for bedside glucose monitoring system Drug Delivery Business

Optiscan Imaging submits 510(k) application to the US FDA - BiotechDispatch

Optiscan Imaging submits 510(k) application to the US FDA BiotechDispatch

Optiscan Imaging oral study published in international medical journal - BiotechDispatch

Optiscan Imaging oral study published in international medical journal BiotechDispatch

OptiScan reels in $20M for broad rollout of automated bedside glucose monitoring system - Fierce Biotech

OptiScan reels in $20M for broad rollout of automated bedside glucose monitoring system Fierce Biotech

Uber-fast Optiscan diagnostic tool a pathology game-changer - The Sydney Morning Herald

Uber-fast Optiscan diagnostic tool a pathology game-changer The Sydney Morning Herald

Optiscan Imaging: Precision Focus - intelligentinvestor.com.au

Optiscan Imaging: Precision Focus intelligentinvestor.com.au

FDA clears OptiScan’s automated bedside glucose monitoring system - Fierce Biotech

FDA clears OptiScan’s automated bedside glucose monitoring system Fierce Biotech

Long Shortz: Optiscan Imaging - NT News

Long Shortz: Optiscan Imaging NT News

Optiscan gets nod for in-surgery breast cancer imaging - The Sydney Morning Herald

Optiscan gets nod for in-surgery breast cancer imaging The Sydney Morning Herald

OptiScan Biomedical Nabs $20M for FDA-Cleared Continuous Glucose Bedside Monitor for ICU - HIT Consultant

OptiScan Biomedical Nabs $20M for FDA-Cleared Continuous Glucose Bedside Monitor for ICU HIT Consultant

‘Significant milestone’: Optiscan soars on new InVue imaging device for precision surgery - Stockhead

‘Significant milestone’: Optiscan soars on new InVue imaging device for precision surgery Stockhead

OIL begins breast cancer study in Melbourne - The Australian

OIL begins breast cancer study in Melbourne The Australian

Optiscan (ASX:OIL) - Stockhead

Optiscan (ASX:OIL) Stockhead

Stock Insiders: Optiscan is expanding and the potential is enormous - Stockhead

Stock Insiders: Optiscan is expanding and the potential is enormous Stockhead

Hot Stocks: ALS, Optiscan Imaging, Silver Mines - Sharecafe

Hot Stocks: ALS, Optiscan Imaging, Silver Mines Sharecafe

Optiscan Imaging Featured in Australian Financial Review - BioMelbourne Network

Optiscan Imaging Featured in Australian Financial Review BioMelbourne Network

Optiscan Imaging to market InVivage imaging device - Australian Manufacturing Forum

Optiscan Imaging to market InVivage imaging device Australian Manufacturing Forum

Optiscan looks to AI future with $3m grant - The West Australian

Optiscan looks to AI future with $3m grant The West Australian

Hoof on the till: Peters backs Optiscan med-tech - The Sydney Morning Herald

Hoof on the till: Peters backs Optiscan med-tech The Sydney Morning Herald

Long Shortz with Optiscan Imaging - dailytelegraph.com.au

Long Shortz with Optiscan Imaging dailytelegraph.com.au

Optiscan on mission to revolutionise medical imaging - The West Australian

Optiscan on mission to revolutionise medical imaging The West Australian

Optiscan Imaging Ltd (ASX: OIL) - The Motley Fool Australia

Optiscan Imaging Ltd (ASX: OIL) The Motley Fool Australia

Top Optiscan Imaging Ltd Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant